KLF4 and lung cancer: To evaluate biological significance of the p53-dependent enhancer KLF4-SE, we established the cell malignant transformation model by treating WT and TP53 KO BEAS-2B cells with 0.4 g/L potent lung cancer-specific carcinogen NNK for 10 generations.